Evaluation of Efficacy and Safety of AshwaDaatÂ® Capsule in subjects with Stress and Insomnia â?? An Open label, multi center, non-comparative, interventional, prospective clinical study - NI

ODAAT PHARMA0 个研究点目标入组 30 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Subjects who perceive themselves to be under stress and having a score between 14 -24 on the Perceived Stress Scale (PSS)
•2.Subjects not having any psychiatric conditions other than stress
•3.Subjects willing to follow the procedures as per the study protocol and voluntarily sign an informed consent form.

•1.Subjects suffering from any chronic physical, hormonal or psychiatric illness
•2.Subjects on treatment for stress and insomnia
•3.Subjects using oral or systemic contraceptive medications
•4.Subjects with uncontrolled diabetes and hypertension
•5.Subjects with substance dependence
•6. Chronic alcoholics and Habitual Tobacco chewers.
•7.Known cases of Severe/Chronic hepatic or renal disease.
•8.Known case of any active malignancy.
•9.Subjects giving history of significant cardiovascular event < 12 weeks prior to recruitment.
•10.Subjects having known chronic, contagious infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV.
•11.Known case of having active metabolic or gastrointestinal diseases that may interfere with nutrient absorption, metabolism, or excretion, excluding diabetes.
•12.Subjects using any other investigational drug within 1 month prior to
•recruitment or Subjects currently participating in any other Clinical study
•13.Known hypersensitivity to any of the ingredients used in study drug
•14.Pregnant and Lactating females.
•15.Any other condition due to which patients are deemed to be unsuitable by the investigator for reason(s) not specifically started in the exclusion criteria

发起方

ODAAT PHARMA